| Literature DB >> 34949926 |
Michelle A Stubbs1,2,3, Vanessa L Clark1,2,3, Melissa Mei Yin Cheung4, Lorraine Smith5, Bandana Saini5,6, Janelle Yorke7,8, Eleanor C Majellano1,2,3, Peter G Gibson1,2,9, Vanessa M McDonald1,2,3,9.
Abstract
PURPOSE: Severe asthma, depression and anxiety often co-exist and increase disease burden. Currently there are no published studies investigating severe asthma and psychological comorbidity using arts-based methodology. We aimed to (i) illustrate the individual experience of adults living with severe asthma, with and without symptoms of depression and/or anxiety and (ii) to explore common characteristics depicted in artworks between those groups. PATIENTS AND METHODS: A qualitative arts-based study was conducted. Adults with severe asthma were categorised into two groups according to Hospital Anxiety and Depression Scale scores (<8 on either subscale [SA-D/A] (N=15) or (≥8 on one or both subscales [SA+D/A] (N=15). Art thematic analysis was undertaken using a hybrid approach. The Common-Sense Model of Self-Regulation was used to examine frequencies in artworks.Entities:
Keywords: anxiety; artworks; depression; mental health; severe asthma
Year: 2021 PMID: 34949926 PMCID: PMC8691197 DOI: 10.2147/JAA.S328104
Source DB: PubMed Journal: J Asthma Allergy ISSN: 1178-6965
Severe Asthma Eligibility Criteria
| Severe Asthma Inclusion Criteria | Study Exclusion Criteria |
|---|---|
| (i) Doctor diagnosed severe asthma | (i) Aged under 18 years |
| (ii) Previous evidence of bronchodilator response ≥200mL or 12% (post-bronchodilator FEV1 following administration of 400µg salbutamol); or | (ii) Non-English speaking |
| (iii) Airway hyper-responsiveness in response to any standard challenge agent; or | (iii) Diagnosed cognitive impairment |
| (iv) Peak flow variability (diurnal; variation ≥15% or ≥50mL); and | (iv) Current diagnosis of acute psychosis |
| (v) Prescription of high dose ICS ≥1000mcg with LABA; or | (v) Inability to attend study visits |
| (vi) Maintenance prednisone; and | (vi) Not willing or able to provide consent |
| (vii) FEV1 post bronchodilator: <80% Predicted; or | |
| (viii) FEV1/FVC <70%; or | |
| (ix) ACQ score ≥1.5; or | |
| (x) Severe exacerbation within the previous 12 months with OCS use |
Abbreviations: ICS, Inhaled Corticosteroids; LABA, Long-Acting Beta Agonists; FEV1, Forced Expiratory Volume in one second; FVC, Forced Volume Capacity; ACQ, Asthma Control Questionnaire; OCS, Oral Corticosteroids.
Participant Demographics and Patient-Reported Outcome Measures
| Characteristic | Severe Asthma without Anxiety/Depression (SA-D/A) | Severe Asthma with Depression/Anxiety (SA+D/A) | p-value | ||
|---|---|---|---|---|---|
| N | 15 | 15 | - | ||
| Sex, F (%) | 7 (47) | 10 (67) | 0.27 | ||
| Age (y), median (Q1, Q3) | 67 (43, 79) | 63 (28, 82) | 0.21 | ||
| Education, n (%) | 1.00 | ||||
| High school qualification | 6 (40) | 5 (33) | |||
| Certificate or diploma qualification | 5 (33) | 5 (33) | |||
| Bachelor or higher degree qualification | 4 (27) | 5 (33) | |||
| Age at diagnosis of severe asthma (years), mean ± SD | 42.7 ± 18.7 | 28.3 ± 17.5 | |||
| Exacerbation past 12 months, median (Q1, Q3) | 1.0 (0, 3.5) | 2.0 (1.5, 3.5) | 0.42 | ||
| Hospital admission past 12 months, mean ± SD | 2.1 ± 0.7 | 2.1 ± 0.7 | 0.50 | ||
| Biological therapy, n (%) | 12 (80) | 10 (67) | 0.64 | ||
| Use of maintenance oral corticosteroids, n (%) | 6 (40) | 3 (20) | 0.59 | ||
| ICS dose (beclomethasone equiv. µg/day), median | 2000 (2000, 2000) | 2000 (2000, 2000) | 1.00 | ||
| Formal mental health diagnosis (%) | 1 (7) | 8 (53) | |||
| HADS (anxiety score), mean ± SD | 3.9 ± 2.4 | 11.1 ± 3.2 | |||
| HADS (depression score), mean ± SD | 2.3 ± 1.7 | 8.2 ± 3.9 | |||
| Health-related quality of life and asthma control | |||||
| BIPQ score, mean ± SD | 32 ± 11.7 | 44.2 ± 8.8 | |||
| PCAQ score, mean ± SD | 27.4 ± 3.4 | 26.4 ± 3.8 | 0.45 | ||
| EQ-5D-5L VAS score, mean ± SD | 81.7 ± 11.4 | 67.9 ± 13.3 | |||
| ACQ average score, mean ± SD | 1.3 ± 1.3 | 1.9 ± 1.0 | 0.17 | ||
| AQLQ total score, mean ± SD | 5.8 ± 0.86 | 4.7 ± 0.83 | |||
Notes: Parametric variables are reported as means (standard deviation (SD)) and non-parametric as medians (Q1 and Q3). Student’s t-test (parametric) or the Mann Whitney test (non-parametric) were used for group comparisons. A p-value of <0.05 was considered statistically significant. Bolding indicates a significant p-value of <0.05.
Abbreviations: SD, Standard Deviation; HADS, Hospital Anxiety and Depression Scale; BIPQ, Brief Illness Perception Questionnaire; PCAQ, Perceived Control of Asthma Questionnaire; EQ-5D-5L VAS, Visual Analogue Scale; ACQ, Asthma Control Questionnaire; AQLQ, Asthma Quality of Life Questionnaire.
Figure 1Coding of artwork according to the CSM.
Themes and Illustrative Quotations
| Theme | Severe Asthma without Anxiety/Depression (SA-D/A) | Severe Asthma with Depression/Anxiety (SA+D/A) |
|---|---|---|
| Darkness | 1.a.i I just feel stress, uncomfortable, worried and depressed (female, 64 years) | 1.b.i It’s how I feel about asthma, depression and anxiety. That they all control me and keep me within the brick walls. They keep me from seeing the sunshine (female, 56 years) |
| Impacts | 2.a.i Just the feeling of frustration when I cannot participate or play my activities as I normally would (male, 68 years) A24) | 2.b.i I used to sit outside and look at how nice everything looked, but I would never feel well enough to go out there (male, 29 years) |
| Resilience | 3.a.i This gives a representation of me and my disease and my approach to my disease and managing it the best I can with my respiratory teams and keeping a positive outlook on life (male 67 years) | 3.b.i I need to focus on the good things in my life instead of what’s happening that’s bad (male, 29 years) |
Figure 2(A) Female, 59 years, ACQ6 average score: 4, (SA-D/A). (B) Male, 71 years, ACQ6 average score: 2, (SA+D/A). (C) Female, 49 years, ACQ6 average score: 3, (SA+D/A).
Figure 3(A) Female, 80 years, ACQ6 average score: 2, (SA-D/A). (B) Male, 68 years, ACQ6 average score: 1, (SA-D/A).
Figure 4(A) Female, 59 years, ACQ6 average score: 0, (SA-D/A). (B) Female, 42 years, ACQ6 average score: 2, (SA+D/A).
Figure 5(A) Female, 73 years, ACQ6 average score: 0, (SA-D/A). (B) Female, 35 years, ACQ6 average score: 2, (SA+D/A).